Abeona Therapeutics Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | – | – | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | – | 100.0% | – | – | – | 100.0% | – | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | |
| 2,791.3% | 2,281.3% | 1,181.7% | 2,676.5% | 1,496.3% | 2,654.0% | 1,537.1% | 2,868.1% | 769.5% | – | – | – | – | – | – | – | 113.8% | 308.1% | 36.2% | – | – | 426.8% | 3,047.7% | 700.8% | – | 9,370.6% | 1,305.9% | 45.0% | – | 25.5% | – | – | – | 16.2% | – | 25.0% | – | 52.3% | 40.9% | 36.7% | 43.4% | |
| 100.0% | 100.0% | -1,081.7% | -2,576.5% | -1,396.3% | -2,554.0% | -1,437.1% | -2,768.1% | -669.5% | – | – | – | – | – | – | – | -13.8% | 100.0% | -277.2% | – | – | -326.8% | -2,947.7% | -600.8% | – | -9,270.6% | -11,825.0% | 55.0% | – | -25.5% | – | – | – | -16.2% | – | 75.0% | – | 47.7% | 59.1% | 63.3% | 56.6% | |
| 1,491.8% | 1,186.3% | 1,181.7% | 2,676.5% | 1,496.3% | 2,654.0% | 1,537.1% | 2,868.1% | 769.5% | – | – | – | – | – | – | – | 113.8% | 308.1% | 277.2% | – | – | 427.7% | 3,447.7% | 665.8% | – | 9,223.5% | 11,825.0% | 243.5% | – | 261.3% | – | – | – | 188.1% | – | 1,485.8% | – | 123.8% | 109.6% | 44.1% | 99.9% | |
| 1,299.5% | 1,094.9% | 1,624.7% | 1,217.5% | 989.0% | 1,447.9% | 542.0% | 1,676.4% | 290.8% | – | – | – | – | – | – | – | 63.3% | 246.6% | 209.3% | – | – | 146.1% | 1,220.8% | 346.0% | – | 8,355.9% | 5,877.9% | 143.5% | – | 206.4% | – | – | – | 160.6% | – | 4,287.3% | – | 346.5% | 223.6% | 139.1% | 287.7% | |
| 2,912.0% | 2,378.1% | 1,759.1% | 3,989.4% | 1,052.1% | 1,515.8% | 574.8% | 1,781.5% | 320.4% | – | – | – | – | – | – | – | 75.4% | 582.7% | 486.6% | – | – | 1,228.3% | 3,003.5% | 200.0% | – | 9,752.9% | 17,702.9% | 356.5% | – | 442.2% | – | – | – | 332.4% | – | 5,773.0% | – | 470.4% | 323.3% | 183.3% | 384.3% | |
| -2,812.0% | -2,278.1% | -2,840.9% | -3,889.4% | -2,448.4% | -4,069.8% | -2,011.9% | -4,549.6% | -989.8% | – | – | – | – | – | – | – | -89.3% | -482.7% | -486.6% | – | – | -1,555.1% | -5,951.2% | -800.8% | – | -19,023.5% | -17,702.9% | -301.5% | – | -467.7% | – | – | – | -348.6% | – | -5,698.0% | – | -422.7% | -264.1% | -120.0% | -327.6% | |
| 0.5% | 0.8% | 1.1% | 1.4% | 0.9% | 0.5% | 0.6% | 1.1% | 0.2% | – | – | – | – | – | – | – | 19.0% | 46.3% | 47.3% | – | – | 2.2% | 58.1% | 20.0% | – | 261.8% | 148.5% | 2.9% | – | 3.9% | – | – | – | 22.6% | – | 239.3% | – | 16.3% | 9.5% | 6.1% | 13.0% | |
| -1,426.1% | -2,735.2% | -2,821.0% | -3,815.2% | -2,439.7% | -3,930.2% | -1,593.8% | -4,239.1% | -960.7% | – | – | – | – | – | – | – | -103.4% | -527.6% | -533.4% | – | – | -1,556.1% | -6,371.1% | -409.7% | – | -10,472.1% | -13,392.6% | -475.8% | – | -587.5% | – | – | – | -194.3% | – | 31,086.3% | – | -381.5% | -195.8% | -177.4% | -306.8% | |
| 1,386.4% | -456.3% | 21.0% | 75.6% | 9.6% | 140.0% | 29.4% | 114.9% | 29.3% | – | – | – | – | – | – | – | 4.8% | 1.3% | 0.5% | – | – | 2.2% | 57.8% | -117.3% | – | -11,089.7% | 1,244.7% | 20.5% | – | 24.0% | – | – | – | -14.2% | – | 3,878.0% | – | -4.0% | 0.0% | – | – | |
| -1,426.1% | -2,735.2% | -2,821.0% | -3,815.2% | -2,439.7% | -3,930.2% | -1,593.8% | -4,239.1% | -960.7% | – | – | – | – | – | – | – | -103.4% | -527.6% | -533.4% | – | – | -1,556.1% | -6,371.1% | -409.7% | – | -10,472.1% | -13,392.6% | -475.8% | – | -587.5% | – | – | – | -194.3% | – | 27,208.3% | – | -377.5% | -195.8% | -177.4% | -246.4% | |
| -1,304.9% | -2,637.5% | -2,685.5% | -3,718.4% | -2,375.8% | -3,861.9% | -1,949.7% | -4,329.7% | -931.0% | – | – | – | – | – | – | – | -72.3% | -444.6% | -449.9% | – | – | -446.0% | -3,934.1% | -869.5% | – | -16,554.4% | -11,938.2% | -448.9% | – | -558.1% | – | – | – | -155.5% | – | 31,517.5% | – | -345.0% | -176.3% | -165.2% | -279.9% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.